相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Diphenhydramine may be a preventive medicine against cisplatin-induced kidney toxicity
Hirofumi Hamano et al.
KIDNEY INTERNATIONAL (2021)
Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin
Xuefei Zhang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Drugs Repurposed as Antiferroptosis Agents Suppress Organ Damage, Including AKI, by Functioning as Lipid Peroxyl Radical Scavengers
Eikan Mishima et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Pt(II) versus Pt(IV) in Carbene Glycoconjugate Antitumor Agents: Minimal Structural Variations and Great Performance Changes
Alfonso Annunziata et al.
INORGANIC CHEMISTRY (2020)
VDR activation attenuate cisplatin induced AKI by inhibiting ferroptosis
Zhaoxin Hu et al.
CELL DEATH & DISEASE (2020)
High-Throughput Screening for the Discovery of Iron Homeostasis Modulators Using an Extremely Sensitive Fluorescent Probe
Tasuku Hirayama et al.
ACS SENSORS (2020)
Ferroptosis, a new form of cell death: opportunities and challenges in cancer
Yanhua Mou et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Ferroptosis as a target for protection against cardiomyopathy
Xuexian Fang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Iron accumulation causes impaired myogenesis correlated with MAPK signaling pathway inhibition by oxidative stress
Yasumasa Ikeda et al.
FASEB JOURNAL (2019)
Ferroptosis: A Novel Anti-tumor Action for Cisplatin
Jipeng Guo et al.
CANCER RESEARCH AND TREATMENT (2018)
Ferroptosis, but Not Necroptosis, Is Important in Nephrotoxic Folic Acid-Induced AKI
Diego Martin-Sanchez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Dietary iron restriction alleviates renal tubulointerstitial injury induced by protein overload in mice
Yasumasa Ikeda et al.
SCIENTIFIC REPORTS (2017)
Inhibition of neuronal ferroptosis protects hemorrhagic brain
Qian Li et al.
JCI INSIGHT (2017)
A Role for Tubular Necroptosis in Cisplatin-Induced AKI
Yanfang Xu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
A Speciation Study on the Perturbing Effects of Iron Chelators on the Homeostasis of Essential Metal Ions
Guido Crisponi et al.
PLOS ONE (2015)
Regulation of Ferroptotic Cancer Cell Death by GPX4
Wan Seok Yang et al.
CELL (2014)
Ferrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models
Rachid Skouta et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Jose Pedro Friedmann Angeli et al.
NATURE CELL BIOLOGY (2014)
Synchronized renal tubular cell death involves ferroptosis
Andreas Linkermann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Pathophysiology of Cisplatin-Induced Acute Kidney Injury
Abdullah Ozkok et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Iron reduction by deferoxamine leads to amelioration of adiposity via the regulation of oxidative stress and inflammation in obese and type 2 diabetes KKAy mice
Soichiro Tajima et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
Lipid Peroxidative Damage on Cisplatin Exposure and Alterations in Antioxidant Defense System in Rat Kidneys: A Possible Protective Effect of Selenium
Branka I. Ognjanovic et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Mechanisms of Cisplatin Nephrotoxicity
Ronald P. Miller et al.
TOXINS (2010)
Cellular Responses to Cisplatin-Induced DNA Damage
Alakananda Basu et al.
JOURNAL OF NUCLEIC ACIDS (2010)
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
N. Pabla et al.
KIDNEY INTERNATIONAL (2008)
Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2
G Ciarimboli et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial
JT Santoso et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2003)
分享论文
